1 / 4

Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) | e

Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) is organized by EB Medicine and will be held from Jun 01, 2019 - Jun 01, 2022.

emedevents123
Download Presentation

Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) | e

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Home / Online CME / Journal CME / Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) (Jun 01, 2019 - Jun 01, 2022)  Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) CME : 4    Save Start Date :  Jun 01 - 2019 End Date :  Jun 01 - 2022 Organized by :  EB Medicine Specialities :  Pediatrics Allergy and Immunology Interested Overview Create PDF in your applications with the Pdfcrowd HTML to PDF API Credit Info Peers Info Contact us Conference Summary Anaphylaxis in Pediatric Patients: Early Recognition and Treatment Are Critical for Best Outcomes (Pharmacology CME) is organized by EB Medicine. Date of Original Release: June 1, 2019 Date of most recent review: May 15, 2019 Termination date: June 1, 2022 CME Expiration Date: July 1, 2022 Target Audience: This enduring material is designed for emergency medicine physicians, physician assistants,

  2. nurse practitioners, and residents. CME Credits: 4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits.  Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits Full Issue: Many cases of anaphylaxis are misdiagnosed or undertreated. This issue offers guidance on the identi?cation of patients with anaphylaxis, including those with atypical presentations, provides evidence-based recommendations for ?rst- and second-line treatment, and discusses guidelines for patient disposition. You will learn: • Clinical criteria for diagnosing patients with anaphylaxis • Common causes of anaphylaxis • Risk factors for biphasic reactions and fatal anaphylaxis • Key historical questions and physical examination ?ndings that help identify patients with anaphylaxis • Which route of epinephrine administration is recommended and the appropriate dosing for pediatric patients • When second-line treatments, such as antihistamines or corticosteroids, can be considered • Guidelines for how long to observe patients in ED and • when patients should be admitted • Appropriate disposition of patients with anaphylaxis, including prescribing epinephrine autoinjectors and offering training on how to use them, educating patients and families on avoidance of known offending allergens, and referring the patient to a specialist in allergy immunology Goals:  Upon completion of this activity, you should be able to:  (1) demonstrate medical decision-making based on the strongest clinical evidence;  (2) cost-effectively diagnose and treat the most critical presentations; and  (3) describe the most common medicolegal pitfalls for each topic covered. CME Objectives: Upon completion of this article, you should be able to: • Recognize atypical presentations of anaphylaxis and identify risk factors for fatal anaphylaxis • Differentiate other disease entities with signs and symptoms similar to anaphylaxis • Administer ?rst-line and/or second-line anaphylaxis treatment(s) according to recommendations in national guidelines • Provide anticipatory discharge guidance and referral to appropriate follow-up care for patients with anaphylaxis Create PDF in your applications with the Pdfcrowd HTML to PDF API Credit Info

  3. CME : 4 Peers Info Number of Health Care Professionals Registered: 0 Number Contact Us Toll free Number 1(800) 826-2059 Email support@eMedEvents.com Chat Assistant Live Chat Add Review Browse CME / CE Conferences by Specialty   View All Cardiology Clinical Pharmacology Dentistry Dermatology Endocrinology, Metabolism and D… Emergency Medicine Endocrinology Gastroenterology Haematology Healthcare Management Infectious Disease Medical Education Medicine Neurology Nursing Nutrition Obstetrics and Gynecology Oncology Ophthalmology Create PDF in your applications with the Pdfcrowd HTML to PDF API Orthopedics Pain Management Pediatrics Pharmacy and Medicine Primary Care Psychiatry Psychology Pulmonary Medicine Radiology Rheumatology Surgery For Physicians Logistics Medical Resources

  4. Quick Links For Organizers Pharma & Medical Devices For Speakers eMedEvents ☰ Follow Us On Download Terms & Conditions | Security | Cookies        Create PDF in your applications with the Pdfcrowd HTML to PDF API

More Related